367
Participants
Start Date
May 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
June 30, 2013
CO-1.01
1250 mg/m2 intravenous infusion weekly for 3 weeks every 4 weeks
Gemcitabine
1000 mg/m2 intravenous infusion weekly for 7 weeks followed by 1 week rest, then weekly for 3 weeks every 4 weeks
Cliniques Universitaires Saint Luc, Brussels
Newcastle Private Hospital, New Lambton Heights
Port Macquarie Base Hospital, Port Macquarie
Southern Medical Day Oncology Care Centre, Wollongong
Universitair Ziekenhuis Antwerpen, Edegem
Saint Vincent's Hospital, Fitzroy
Border Medical Oncology, Murray Valley Private Hospital, Wodonga
Sørlandet sykehus HF, Kristiansand
Flinders Medical Centre, Bedford Park
Centre Hospitalier de Jolimont-Lobbes, Haine-Saint-Paul
Arena Oncology Associates, PC, Lake Success
Charité Universitätsmedizin Berlin, Berlin
Fundacao Hospital, Jaú
Klinikum der Ernst-Moritz-Arndt-Universität, Greifswald
Fondazione San Raffaele del Monte Tabor, Milan
Instituto Nacional do Cancer, Rio de Janeiro
Annapolis Oncology Center, Annapolis
Cancer Center of the Carolinas, Greenville
Hôpital Saint André, Service d'Oncologie Médicale, Bordeaux
Centre Hospitalier Régional Universitaire Hôpital Saint Eloi, Montpellier
Centre Regional de Lutte contre le Cancer Val d'Aurelle, Montpellier
Instituto Oncologico Veneto, Oncologia Medica 1, Padua
Centro Ricerche Cliniche di Verona, Verona
Klinik der Otto-Von-Guericke-Universität Magdeburg, Magdeburg
Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna
Centre René Gauducheau, Saint-Herblain
Knappschaftskrankenhaus Bochum-Langendreer, Bochum
Dnipropetrovsk City Multispecialty Clinical Hospital #4, Department of Chemotherapy, Dnipropetrovsk State Medical Academy, Department of Oncology and Medical Radiology, Dnipropetrovsk
Medical College of Wisconsin, Milwaukee
Mykolayiv Regional Oncology Center, Surgery Department #1, Mykolayiv
Virginia Piper Cancer Institute, Minneapolis
Ospedali Riuniti di Ancona, Torrette Di Ancona
"Public Healthcare Institution Kharkiv Regional Clinical Oncology Center, Abdominal Department", Kharkiv
Centre Hospitalier de la Cote Basque, Bayonne
"Clinical Facility: Public Institution Zaporizhya City Clinical Hospital #3, Regional Center of Hepatic, Biliary Tract and Pancreatic Surgery, Surgery Department #1", Zaporizhya
Hospital Universitario, Brasília
South Texas Oncology and Hematology, PA, San Antonio
Cancer Specialists of South Texas, P.A., Corpus Christi
Valley Cancer Associates, Harlingen
State Regional Diagnostics and Treatment Oncology Center, Chemotherapy Department, Lviv
Rocky Mountain Cancer Centers, Denver
Ludwig-Maximilians-Universität, Medizinische Klinik und Poliklinikversität München, München
"Public Clinical Treatment and Prophylaxis Institution Donetsk Regional Antitumor Center, Oncosurgery Department #6", Donetsk
Arizona Center for Hematology Oncology, Glendale
Clinique François Chénieux, Limoges
New Mexico Cancer Care Alliance, Albuquerque
Zakarpatya Regional Clinical Oncology Center, Chemotherapy Department, Uzhhorod
Medizinische Universitätsklinik Ulm, Abt. Innere Medizin I, Ulm
Irmandade da Santa, Porto Alegre
White Memorial Medical Center, Los Angeles
Cancer Care Institute, Los Angeles
Sharp Clinical Oncology Research, San Diego
Newport Cancer Care Medical, Newport Beach
Wilshire Oncology Medical Group, Inc., Corona
Hematology Oncology Associates, Oakland
Institut Gustave-Roussy - Centre de Lutte Contre le Cancer, Villejuif
Bend Memorial Clinic, Bend
Blokhin Cancer Research Center, Moscow
Regional Clinical Oncology Hospital, Yaroslavl
Leningrad Regional Clinical Hospital, Saint Petersburg
Mechnikov St. Petersburg State Medical Academy, Saint Petersburg
St. Petersburg City Oncology Center, Saint Petersburg
Tula Regional Oncology Center, Tula
Kursk Regional Oncology Center, Kursk
Clinical Oncology Center #1, Krasnodar
Tambov Regional Oncology Center, Tambov
Republic Clinical Oncology Center, Izhevsk
Sverdlovsk Regional Oncology Center, Yekaterinburg
Novosibirsk, City Clinical Hospital #1, Novosibirsk
Regional Oncology Center, Irkutsk
Hartford Hospital Clinical Research, Hartford
Oncology Associates of Bridgeport, Trumbull
The Cancer Institute of New Jersey, New Brunswick
Policlínica Privada Instituto de Medicina Nuclear, Buenos Aires
Instituto Especializado Alexander Fleming, Cuidad Autónoma de Buenos Aires
Hospital de Gastroenterología, Loma Hermosa
Clínica Universitaria Reina Fabiola, Córdoba
ISIS Centro Especializado, Santa Fe
Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte
Hospital São Lucas - PUCRS, Porto Alegre
CEPON-Centro de pesquisas Oncologicas, Florianópolis
Hospital do Cancer de Barretos, Barretos
Faculdade de Medicina do ABC, Santo André
Cross Cancer Institute, Edmonton
Universitätsklinikum Jena, Jena
Universitätsklinikum Carl Gustav Carus, Dresden
Vrije Universiteit Medisch Centrum, Amsterdam
Oslo Universitetssykehus, Ullevål, Oslo
Lanssjukhuset Ryhov, Jönköping
Linköping University Hospital, Linköping
Växjö Centrallasarettet, Vaxjo
National Cancer Institute, Department of Tumors of Abdominal Cavity and Retroperitoneum, Kiev
Hammersmith Hospital, London
Christie Hospital, Manchester
Beatson West of Scotland Cancer Centre, Cancer Research UK Clinical Trials Unit (CTU), Glasgow
Lead Sponsor
Clovis Oncology, Inc.
INDUSTRY